...
首页> 外文期刊>Archives of Biochemistry and Biophysics >Crosstalk between NRF2 and Dicer through metastasis regulating MicroRNAs; mir-34a, mir-200 family and mir-103/107 family
【24h】

Crosstalk between NRF2 and Dicer through metastasis regulating MicroRNAs; mir-34a, mir-200 family and mir-103/107 family

机译:NRF2与DICER之间的串扰通过转移调节MicroRNA; mir-34a,mir-200家族和mir-103/107家庭

获取原文
获取原文并翻译 | 示例

摘要

Oxidative stress due to generation of reactive oxygen species (ROS) can cause damage to cellular proteins, lipids and DNA, which is one of crucial causes responsible for cancer. Nuclear factor erythroid 2 [NF-E2]-related factor 2 (NRF2) is a transcription factor of a variety of antioxidant and cytoprotective enzymes, so that it reduces the levels of damaging ROS in the cell. Over expression of NRF2 in cancer cells can enhance cancer progression, confer resistance to chemo and radiotherapy, and metastasis through the process of epithelial-to mesenchymal transition (EMT); which is a hallmark of cancer-related death. Dicer, a key component of the microRNAs biogenesis, is a ribonuclease enzyme which involves in maturation of microRNAs that have a role in distinct steps of metastasis cascade. Moreover, Dicer was found to be regulated by ROS/NRF2 interaction to contribute to activation of DNA damage repair mechanism. In addition, Dicer is directly reduced by mir-103/107 family that confers migratory capacity through down-regulation of mir-200 family (mir-200b/mir-200c/mir-429). Mir-200c and mir-34a were predicted to target the repressor of NRF2; Sirt1. On the other hand, mir-200a and mir-141 (mir-200 family) were detected to regulate NRF2 expression. This review highlights the regulation of redox homeostasis that is mediated by NRF2 could be modulated by metastasis regulating microRNAs under the control of Dicer. In addition, NRF2 may indirectly control DNA damage repair and microRNAs processing machinery through the crosstalk between NRF2 and Dicer. Understanding such interrelations could provide and shed light on the significance of microRNA-based therapies that will improve the action of clinically used cancer treatments.
机译:由于反应性氧物质(ROS)产生引起的氧化应激会导致细胞蛋白,脂质和DNA损伤,这是对癌症负责的关键原因之一。核因子红细胞2 [NF-E2] - 相关因子2(NRF2)是各种抗氧化剂和细胞保护酶的转录因子,从而降低细胞中损伤RO的水平。在癌细胞中NRF2的表达可以增强癌症进展,赋予化疗和放射疗法的抵抗力,通过上皮 - 间充质转换(EMT)的过程转移;这是癌症相关死亡的标志。 Dicer是微大RORNA生物发生的关键组分,是一种核糖核酸酶酶,其涉及在MicroRNA的成熟中,其在转移级联的不同步骤中具有作用。此外,发现DICER由ROS / NRF2相互作用调节,以有助于激活DNA损伤修复机制。此外,Dicer直接由MiR-103/107系列减少,通过MiR-200家族的下调(miR-200b / miR-200c / miR-429)来赋予迁移能力。预计MiR-200c和miR-34a靶向NRF2的阻遏物; SIRT1。另一方面,检测miR-200a和miR-141(miR-200系列)以调节NRF2表达。该综述突出了调节NRF2介导的redox稳态可以通过在Dicer的控制下通过转移调节MicroRNA来调节。此外,NRF2可以通过NRF2和DICER之间的串扰间接控制DNA损伤修复和MicroRNA加工机械。了解这些相互关系可以提供和阐明基于MicroRNA的疗法的重要性,这将改善临床使用的癌症治疗的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号